CBD /

 

Loading...
Country's Decision or any other Communication (DEC)
  |  
BCH-DEC-CO-105618-1   |   PDF   |   Print   |  
| 
|  Close
last updated: 12 Jun 2014
Amendment
No
General Information
Colombia
Resolución 2400: Por la cual se autoriza el uso (importación y comercialización) a la empresa Vetiplus S.A. de la vacuna aviar recombinante para inmunización activa contra la enfermedad de Marek (MD) y la enfermedad de Newcsatle) (ND)
ES
19 Jul 2010
No
Subject of the decision, notification, communication or declaration
  • Decision on Pharmaceuticals (Article 5)
LMO identification & risk assessment
  • BCH-LMO-SCBD-105260-1 Living Modified Organism VECTORMUNE® HVT-IBD
    Ceva Saúde Animal Ltda(CEVA) | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
  • BCH-RA-CO-105617-1 Risk Assessment generated by a regulatory process Uso de la vacuna aviar recombinante para inmunización activa contra la enfermedad de Marek (MD) y la enfermedad de Newcastle (ND)
    VECTORMUNE® HVT-IBD | Turkey herpesvirus, Meleagrid herpesvirus 1, Production of medical or pharmaceutical compounds (human or animal)
Document on the decision, communication, notification or declaration

Quick links

About the BCH About the Cartagena Protocol Supplementary Protocol

Sign in Search records Submit records
Registries: LMO-Organism-Gene Country Profiles
National Report Analyzer

Forums BCH Announcements

Need help?

Knowledge Base FAQs UNEP eLearning Training Site

Contact us at: bch@cbd.int
BCH Biosafety Clearing-House
Subscribe to e-mail notifications
Subscribe to our newsletter